Volume adaptation in chronic liver disease: on the static and dynamic location of water, salt, protein and red cells in cirrhosis

References

• Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vaso-dilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 5: 1151–7.
   Google Scholar
• Lieberman FL, Reynolds TB. Plasma volume in cirrhosis of the liver. Its relations to portal hypertension, ascites, and renal failure. J Clin Invest 1967; 47: 1297–308.
   Google Scholar
• Kiszka-Kanowitz M, Henriksen JH, Moller S, Bendtsen F. Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique. J Hepatol 2001; 35: 605–12.
   Google Scholar
• Henriksen JH, Bendtsen F, Sorensen TIA, Stadeager C, Ring-Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology 1989; 97: 1506–13.
   PubMed Web of Science ®Google Scholar
• Moller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology 1995; 109: 1917–25.
   Google Scholar
• Colombato LA, Albillos A, Groszmann RJ. The role of central blood volume in the development of sodium retention in portal hypertensive rats. Gastroenterology 1996; 110: 193–8.
   Google Scholar
• Hadengue A, Moreau R, Gaudin C, Bacq Y, Champigneulle B, Lebrec D. Total effective vascular compliance in patients with cirrhosis. A study of the response to acute blood volume expansion. Hepatatology 1992; 15: 809–15.
   Google Scholar
• Henriksen JH, Moller S, Schifter S, Bendtsen F. Increased arterial compliance in decompensated cirrhosis. J Hepatol 1999; 31: 712–8.
   PubMed Web of Science ®Google Scholar
• Henriksen JH, Moller S, Schifter S, Abrahamsen J, Becker U. High arterial compliance in cirrhosis is related to low adrenaline and elevated circulat-ing calcitonin gene related peptide but not to activated vasoconstrictor systems. Gut 2001; 49: 112 — 8.
   Google Scholar
• Levy M, Wexter MJ. Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity. J Lab Clin Med 1978; 91: 520–36.
   PubMedGoogle Scholar
• Bradley SE, Marks PA, Reynall PC, Meltzer J. The circulating splanchnic blood volume in dog and man. Trans Assoc Am Physicians 1953; 66: 294— 302.
   PubMedGoogle Scholar
• Lassen NA, Perl W. Tracer kinetics methods in medical physiology. New York: Raven Press; 1979. p. 1–289.
   Google Scholar
• Larsen OA, Winkler K, Tygstrup N. "Extra" plasma in the liver calculated from the hepatic hematocrit in patients with portacaval anastomo-sis. Clin Sci 1963; 25: 357–60.
   Google Scholar
• Camps J, Sola J, Arroyo V, Perez-Ayuso RM, Gaya J, Rivera F, Rodés J. Temporal relationship between the impairment of free water excretion and antidiuretic hormone hypersecretion in rats with experimental cirrhosis. Gastroenterology 1987; 93: 498–505.
   Google Scholar
• Gines A, Escorsell A, Gines P, Salo J, Jimenez W, Inglada L, Navasa M, Claria J, Rimola A, Arroyo V. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. 1993; 105: 229–36.
   PubMed Web of Science ®Google Scholar
• Abraham WT, Schrier RW. Extracellular fluid volume homeostasis. In: Arroyo V, Ginés P, Rodés J, Schrier RW, editors. Ascites and renal dysfunction in liver disease, pathogenesis, diag-nosis, and treatment. Oxford: Blackwell Science; 1999. p. 129–42.
   Google Scholar
• Epstein M. Renal effects of head-out water immersion in man: implications for an under-standing of volume homeostasis. Physiol Rev 1978; 58: 529–81.
   PubMed Web of Science ®Google Scholar
• Femandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, Cardenas A, Guevara M, Sort P, Jimenez W, Bataller R, Arroyo V, Rodés J. A Prognostic model for predicting survival in cirrhosis with ascites. J Hepatol. 2001; 34: 46–52.
   PubMedGoogle Scholar
• Henriksen JH, Moller S, Ring-Larsen H, Christensen NJ. The sympathetic nervous system in liver disease. J Hepatol 1998; 29: 328–41.
   Google Scholar
• Moller S, Henriksen JH. The systemic circulation in cirrhosis. In: Arroyo V, Ginès P, Rodés J, Schrier RW, editors. Ascites and renal dysfunction in liver disease. Pathogenesis, diagnosis and treatment. Oxford: Blackwell Science; 1999. p. 307–29
   Google Scholar
• Moller S, Henriksen JH. Neurohumoral fluid regulation in chronic liver disease. Scand J Clin Lab Invest 1998; 58: 361–72.
   PubMed Web of Science ®Google Scholar
• Moller S, Bendtsen F, Henriksen JH. Vasoactive substances in the circulatory dysfunction of cirrhosis. Scand J Clin Lab Invest 2001; 61: 421–30.
   PubMed Web of Science ®Google Scholar
• Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996; 24: 451–9.
   PubMed Web of Science ®Google Scholar
• Wong F, Liu P, Lilly L, Bomzon A, Blendis L. Role of cardiac structural and functional abnorm-alities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clin Sci 1999; 97: 259–67.
   Google Scholar
• Pozzi M, Carugo S, Boari G, Pecci V, de Ceglia S, Maggiolini S, Bolla GB. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997; 26: 1131–7.
   Google Scholar
• Moller S, Henriksen JH. Cirrhotic cardiomyopa-thy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002; 87: 9–15.
   PubMed Web of Science ®Google Scholar
• Andreu V, Perello A, Mointinho E, Escorsell A, Garcia-Pagan JC, Bosch J, Rodés J. Total effective vascular compliance in patients with cirrhosis. Effects of propranolol. J Hepatol 2002; 36: 356–61.
   Google Scholar
• Groszmann RJ. Vasodilatation and hyperdynamic circulatory state in chronic liver disease. In: Bosch J, Groszmann RJ, editors. Portal hypertension. Pathophysiology and treatment. Oxford: Black-well; 1994. p. 17–26
   Google Scholar
• Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 2002; 35: 478–91.
   PubMed Web of Science ®Google Scholar
• Ros J, Claria J, To-Figueras J, Planaguma A, Cejudo-Martin P, Fernandez-Varo G, Martin-Ruiz R, Arroyo V, Rivera F, Rodes J, Jimenez W. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenter-ology 2002; 122: 85–93.
   Google Scholar
• Henriksen JH, Gotze JP, Fuglsang S, Christensen E, Bendtsen F, Moller S. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrho-sis: relation to cardiovascular dysfunction and severity of disease. Gut 2003; 52: 1511–7.
   PubMed Web of Science ®Google Scholar
• Nicholls KM, Shapiro MD, Van Putten VJ, Kluge R, Chung HM, Bichet DG, Schrier RW. Elevated plasma norepinephrine concentrations in decom-pensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion. Circ Res 1985; 56: 457–61.
   Google Scholar
• Henriksen JH. Protein-kinetics and haemo-dynamic studies in patients with liver cirrhosis. Clin Physiol 1981; 1: 565–78.
   Google Scholar
• Henriksen JH, Siemssen O, Krintel JJ, Malchow-Moller A, Bendtsen F, Ring-Larsen H. Dynamics of albumin in plasma and ascitic fluid in patients with cirrhosis. J Hepatol 2001; 34: 53–60.
   Google Scholar
• Henriksen JH. Starling, his contemporaries and the Nobel Prize. Scand J Clin Lab Invest 2003; 63 Suppl. 238: 1–64.
   Google Scholar
• Ahlqvist J, Ernest H. Starling and the Nobel Prize. Scand J Clin Lab Invest 2003; 63: 315–6.
   PubMed Web of Science ®Google Scholar
• Parving HH, Rossing N, Jensen HA. Increased metabolic turnover rate and transcapillary escape rate of albumin in essential hypertension. Circ Res 1974; 35: 544–52.
   Google Scholar
• Joffe P, Henriksen JH. Bidirectional peritoneal transport of albumin in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1995; 10: 1725–32.
   PubMedGoogle Scholar
• von Schenk H. Validation of albumin determined in urine with the HemoCue point-of-care analyser. Scand J Clin Lab Invest 2003; 63: 119–26.
   PubMedGoogle Scholar
• Bengmark S. The peritoneum and peritoneal access. London: Wright; 1989. p. 1–374.
   Google Scholar
• Salo J, Ginès A, Ginès P, Piera C, Jimenez W, Guevara M. Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis. J Hepatol 1997; 27: 645–53.
   PubMed Web of Science ®Google Scholar
• Witte CL, Witte MH, Dumont AE. Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis. Gastroenter-ology 1980; 78: 1059–68.
   Google Scholar
• Stanley MM, Shigeru O, Lee KK, Nemchausky BA, Greenlee HB, Allen JI. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med 1989; 321: 1632–8.
   PubMedGoogle Scholar
• Ginès A, Planas R, Angeli P, Guarner C, Salerno F, Ginès P. Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: comparison with therapeutic para-centesis. Hepatology 1995; 22: 124–31.
   Google Scholar
• Henriksen JH. Abnormalities in transsinusoidal fluid exchange in cirrhosis. Local factors in ascites formation. In: Arroyo V, Bosch J, Bruguera M, Rodés J, editors. Therapy in liver disease. The pathological basis of therapy. Barcelona: Masson SA; 1997. p. 51–62.
   Google Scholar
• Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, Mc-Hutchison JG. The serum-ascites albumin gradient is superior to the exudates-transudate concept in the differ-ential diagnosis of ascites. Ann Intern Med 1992; 117: 215–20.
   Google Scholar
• Zaak D, Paquet KJ, Kuhn R. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites. Z Gastro-enterol 2001; 39: 5–10.
   Google Scholar
• Luca A, Garcia-Pagan JC, Bosch J, Feu F, Jimenez W, Gines A. Beneficial effects of intrave-nous albumin infusion on the hemodynamic and humoral changes after total paracentesis. Hepatol-ogy 1995; 22: 753–8.
   PubMedGoogle Scholar
• Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999; 341: 403–9.
   Google Scholar
• Zimmon DS, Kessler RE. The portal pressure-blood volume relationship in cirrhosis. Gut 1974; 15: 99–101.
   PubMed Web of Science ®Google Scholar
• Yu A, Egberg N, Jacobson SH. Haemostatic complications in haemodialysis patients: effect of type of vascular access and dialysis filter. Scand J Clin Lab Invest 2003; 63: 127–34.
   Google Scholar
• Castaneda B, Moreles J, Liontti R, Moitinho E, Andreu V, Perez-Del-Pulgar S, Pizcueta P, Rodés J, Bosch J. Effects of blood volume restitution following a portal hypertensive-related bleeding in anaesthetized cirrhotic rats. Hepatology 2001; 33: 821–5.
   Google Scholar
• Henriksen JH, Bendtsen F, Moller S. Normal red cell cardiac output in the hyperkinetic syndrome of alcoholic cirrhosis. J Hepatol 2001; 34: 782–3.
   Google Scholar
• Moreau R, Lee SS, Hadenque A, Ozier Y, Sicot C, Lebrec D. Relationship between oxygen transport and oxygen uptake in patients with cirrhosis: effects of vasoactive drugs. Hepatology 1989; 9: 427–32.
   PubMed Web of Science ®Google Scholar
• Davis GK. Role of cardiac troponin testing in percutaneous transluminal coronary angioplasty. Scand J Clin Lab Invest 2003; 63: 167–74.
   PubMed Web of Science ®Google Scholar
• Moller S, Becker U, Schifter S, Abrahamsen J, Henriksen JH. Effect of oxygen inhalation on systemic, central, and splanchnic haemodynamics in cirrhosis. J Hepatol 1996; 25: 316–28.
   Google Scholar
• Koskenvuo JW, Saraste M, Niemi P, Knuuti J, Sakuma H, Toikka JO, Komu M, Järvisalo MJ, Hartiala JJ. Correlation of transthoracic Doppler echocardiography and magnetic resonance ima-ging in measuring left anterior descending artery flow velocity and time-course of dipyridamole-induced coronary flow increase. Scand J Clin Lab Invest 2003; 63: 65–72.
   Google Scholar
• Elizalde JI, Moitinho E, Carcia-Pagán JC, Cirera I, Escorsell A, Bandi JC. Effects of increasing blood hemoglobin levels on systemic hemo-dynamics of acutely anemic cirrhotic patients. J Hepatol 1998; 29: 789–95.
   Google Scholar
• Cirera I, Elizalde JI, Piqué JM, Feu F, Casadevall M, Goldin E. Anaemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension. Dig Dis Sci 1997; 42: 1697–702.
   Google Scholar
• Pozzi M, Osculati G, Boari G, Serboli P, Colombo P, Lambrughi C. Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites. Gastroenterology 1994; 106: 709–19.
   PubMed Web of Science ®Google Scholar
• Jarmuzewska EA, Ghidoni A, Mangoni AA. Relative preservation of the renin-angiotensin-aldosterone system response to active orthostatism in type 2 diabetic patients with autonomic neuropathy and postural hypotension. Scand J Clin Lab Invest 2003; 63: 225–32.
   Google Scholar
• Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Moller S. Arterial compliance in patients with cirrhosis. High stroke volume/pulse pressure ratio as an index of elevated arterial compliance. Am J Physiol Gastroint Liver Physiol 2001; 280: G584–94.
   Google Scholar
• Rowell LB. Human cardiovascular control. New York, Oxford: Oxford University Press; 1993. p. 1 —500
   Google Scholar
• Stergiopulos N, Meister JhyphenJ, Westerhof N. Evaluation of methods for estimation of total arterial compliance. Am J Physiol Heart Circ Physiol 1995; 268: H1540–8.
   PubMed Web of Science ®Google Scholar
• Gentilini P, Romanelli RG, Laffi G, Barletta G, Del Bene R, Messeri G, La Villa G. Cardio-vascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. J Hepatol 1999; 30: 632–8.
   Google Scholar
• Brinch K, Moller S, Bendtsen F, Becker U, Henriksen JH. Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease. J Hepatol 2003; 39: 24–31.
   Google Scholar
• Henriksen JH, Ring-Larsen H. Renal effects of drugs used in the treatment of portal hypertension. Hepatology 1993; 18: 688–95.
   PubMed Web of Science ®Google Scholar
• D'Amico G. The role of vasoactive drugs in the treatment of oesophageal varices. Expert Opin Pharmacother 2004; 5: 349–60.
   PubMedGoogle Scholar
• Moller S, Hansen EF, Becker U, Brinch K, Henriksen JH, Bendtsen F. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver 2000; 20: 51–9.
   PubMedGoogle Scholar
• Henriksen JH, Bendtsen F, Gerbes AL, Christensen NJ, Ring-Larsen H, Sorensen TIA. Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, 13-adrenergic blockade and atrial natriuretic factor. Hepatology 1992; 16: 1163–70.
   Google Scholar
• Lin HC, Tsai YT, Yang MC, Lee FY, Hou MC, Chen LS, See SD. Effect of octreotide on total effective vascular compliance in patients with posthepatitic cirrhosis. J Hepatol 1996; 24: 81–7.
   Google Scholar
• Ingles AC, Hernandez I, Garcia-Estan J, Quesada T, Carbonell LF. Increased total vascular capacity in conscious cirrhotic rats. Gastroenterology 1992; 103: 275–81.
   Google Scholar
• Moller S, Bendtsen F, Henriksen JH. Effect of beta-adrenergic blockade on elevated arterial compliance and low systemic vascular resistance in cirrhosis. Scand J Gastroenterol 2001; 36: 653–7.
   Google Scholar
• Kusserow H, Unger T. Vasoactive peptides, their receptors and drug development. Basic Clin Pharmacol Toxicol 2004; 94: 5–12.
   PubMed Web of Science ®Google Scholar
• Ortega R, Gines P, Uriz J, Cardenas A, Calahorra B, De Las Heras D, Guevara M, Bataller R, Jimenez W, Arroyo V, Rodes J. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospec-tive, nonrandomized study. Hepatology 2002; 36: 941–8.
   Google Scholar
• Therapondos G, Stanley AJ, Hayes PC. Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: pilot study. J Gastroenterol Hepatol 2004; 19: 73–7.
   Google Scholar
• Kiszka-Kanowitz M, Henriksen JH, Hansen EF, Moller S, Bendtsen F. Effect of terlipressin on blood volume distribution in patients with cirrho-sis. Scand J Gastroenterol 2004; 39: 486–92.
   Google Scholar
• Henriksen JH, Schlichting P. Increased extravasa-tion and lymphatic return rate of albumin during diuretic treatment of ascites in patients with liver cirrhosis. Scand J Clin Lab Invest 1981; 41: 589–99.
   PubMed Web of Science ®Google Scholar
• Henriksen JH, Parving H-H, Lassen NA, Winkler K. Increased transvascular escape rate and lymph drainage of albumin in pigs during intravenous diuretic medication. Relations to treatment in man and transport mechanisms. Scand J Clin Lab Invest 1982; 42: 423–9.
   Google Scholar
• Fernandez-Varo G, Ros J, Morales-Ruiz M, Cejudo-Martin P, Arroyo V, Sole M, Rivera F, Rodes J, Jimenez W. Nitric oxide synthase 3-dependent vascular remodelling and circulatory dysfunction in cirrhosis. Am J Pathol 2003; 162: 1985–93.
   Google Scholar